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Tulane virus (TV) is a cultivable calicivirus isolated from rhesus monkeys. In this study, we
characterized the substrate speciﬁcity of TV protease in trans using recombinant proteases and TV
polyprotein fragments containing the predicted proteolytic cleavage sites. Cleavage products have
been obtained from 4 of the 5 fragments containing 573Q–S574 between the helicase and 3A-like protein,
712E–A713 between the 3A-like protein and Vpg, 802E–G803 between Vpg and the protease, and
976E–G977 between the protease and RdRp. We also characterized the enzymatic activities of the
recombinant proteases of TV and Norwalk virus using synthetic ﬂuorogenic peptide substrates. Under
optimal conditions for enzymatic assays, partial cross-reactivities on reciprocal substrates were
observed between TV and Norwalk virus proteases. The apparently shared substrate speciﬁcities
between TV and Norwalk virus proteases suggested that the cultivable TV could be used as a model for
in vivo evaluation of lead candidates of protease inhibitors for human norovirus.
& 2012 Elsevier Inc. All rights reserved.Introduction
Caliciviruses (CVs) are small, non-enveloped, positive-stranded
RNA viruses. Members of the CV family can cause a wide variety of
diseases in humans and animals, including respiratory infections,
vesicular lesions, gastroenteritis, and hemorrhagic diseases. Nor-
ovirus (NoV) belongs to one of the ﬁve genera of CVs which mainly
infects humans and causes acute gastroenteritis in all age groups
(Glass et al., 2009). Currently, there are no effective treatments or
vaccines available against NoVs. The lack of a cell culture system or
animal model for NoVs has been a major hurdle for studies of NoV
replication and pathogenesis.
Tulane virus (TV) is a CV isolated recently from stools of rhesus
monkeys. Like most other CVs, the TV genome encodes three open
reading frames (ORFs). ORF1 encodes a non-structural polypro-
tein, whereas ORF2 and ORF3 encode a major and a minor
structural protein, respectively (Farkas et al., 2008; Glass et al.,
2000; Jiang et al., 1993). TV has a similar genome organization as
other CVs, and has been proposed to comprise a new genus,
named recovirus (Farkas et al., 2008). Evolutionarily, TV is more
closely related to NoVs than to any other genera of Caliciviridae
(Farkas et al., 2008). At a total of 6714 nucleotides (nt) in length,
TV represents the smallest genome in the CV family. TV has beenll rights reserved.
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36 7655.successfully cultivated in the rhesus monkey kidney cell line
LLC-MK2 and causes cytopathic effect (CPE) upon infection of these
cells. A reverse genetics system of TV has been established, which
makes TV an ideal surrogate for NoV studies (Wei et al., 2008).
The CV non-structural polyprotein is known to be processed
into six functional proteins by the viral 3C like protease (Blakeney
et al., 2003), which plays an essential role in maturation of
functional proteins and virus replication, as well as pathogenesis.
The crystallographic structures of several NoV proteases have
been elucidated (Hussey et al., 2010; Nakamura et al., 2005;
Zeitler et al., 2006). These data suggest that NoV proteases form
dimers (Nakamura et al., 2005; Zeitler et al., 2006) and display a
trypsin or chymotrypsin-like serine protease fold, involving a
nucleophilic cysteine thiol (at amino acid residue 139) in the
catalytic triad (Zeitler et al., 2006). Two other critical residues in
the catalytic site, completing the catalytic triad, are a histidine at
position 30 and a glutamic acid at position 54 (Zeitler et al., 2006).
Alignments of amino acid sequences for TV, NoV, and other CV
proteases revealed that the critical residues in the catalytic triad
are well conserved.
The proteases of the CV family cleave substrates between Glu
or Gln in the P1 position and various amino acid residues, such as
Ala and Gly in the P10 position (Belliot et al., 2003; Blakeney et al.,
2003; Joubert et al., 2000; Liu et al., 1999; Oka et al., 2005; Robel
et al., 2008; Sosnovtsev et al., 2006, 2002; Wirblich et al., 1995).
Amino acid residues adjacent to P1–P10 positions may also affect
substrate speciﬁcities and cleavage efﬁciencies (Oka et al.,
2009; Someya and Takeda, 2009). Sequence alignments of the
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polyprotein cleavage maps revealed the presence of putative
cleavage sites in the TV polyprotein (Farkas et al., 2008). However,
the precise proteolytic cleavages of TV polyprotein have not been
analyzed to date.
Here we report an investigation into the proteolytic processing
of the TV nonstructural polyprotein in vitro using E. coli-expressed
protease and polyprotein fragments. N-terminal sequencing of four
cleaved products indicated that these cleavages occur precisely at
the predicted sites, which suggests conservation of the substrate
speciﬁcities between the TV protease and other CV proteases. We
also characterized the enzymatic activities of the recombinant TV
protease and NoV protease using recombinant polyprotein frag-
ments and ﬂuorescence resonance energy transfer (FRET) assays.
Our results demonstrated that the ﬂuorescence-based assay is
sensitive and reliable for the evaluation of CV protease activities,
and that the cultivable TV could be used as a model for in vivo
validation of lead protease inhibitor candidates.Results
Expression and puriﬁcation of recombinant proteases. To
obtain an adequate amount of proteases for enzymatic character-
ization, we expressed the TV and a NoV (the Norwalk virus)
proteases as the GST or histidine (His) tagged fusion proteins, as
suggested by Zeitler et al. (Zeitler et al., 2006). Both the GST- and
His-tag proteins were soluble and readily puriﬁed using non-
denaturing afﬁnity puriﬁcation methods. The puriﬁed enzymes
appeared homogeneous by the SDS-polyacrylamide gel electro-
phoresis (PAGE) and FPLC analyses (Fig. 1). Puriﬁed proteases
with the His-tag or after removal of the GST tag appeared as
monomers in solution for both TV and Norwalk virus proteases by
comparison with the chymotrypsinogen A standard (molecular
weight of 20.4 kDa) in the FPLC analysis (data not shown).
Proteolytic cleavage between the helicase and 3A-like
protein. To facilitate the proteolitic analysis of TV polyprotein,
recombinant protein fragments containing different regions of the
polyprotein were produced. To analyze the cleavage site between
the helicase and 3A-like protein, the coding region for amino acid
residues 495 to 795 was expressed as a MBP fusion protein
(79.7 kDa; Fig. 2A, F2). Proteolytic cleavage of this protein by
the TV protease yielded four major bands at approximately
54 kDa, 45 kDa, 30 kDa, and 16 kDa respectively. Two of which
were readily detected by a TV 3A-like protein speciﬁc antibody in
a Western blot analysis: a30 kDa fragment was likely to containTable 1
Primers used for the ampliﬁcation of NoV protease, TV protease, and TV polyprotein fr
Primers Sequence
P1405b CGCGGATCCGCTCCCCCGACACTATGGAGCCGAG
P1406 ATGGTCGACTCATTCTAGTGCGGTTTCGCC
P1069c CGCGGATCCGTGTGTTCTTTTGTCTTC
P1071b ATAGTCGACTCACCCTTCAAGGTTGAATCTAGAAG
p1282b ACTGGTACCTCAGATGAATATCCAGAGC
p1283b ATGGTCGACTCACTCAAACACGCTAAGTGC
P1095 AATGGATCCATGGATACGTCCATAGATTC
P1077 ATAGTCGACTCAGGAGCATCCCAACTGGAG
P1403 TGGAATTCACCACAAACTTGGAGGAC
P1404 ATGGTCGACTCACTCGTCGTAATAATCATCACT
P1890 TGAGGATCCCTCGATGGATACCTCACTG
P1891 ACTGTCGACCACCACTCATCATCTTC
P1069 CGCGGATCCCCCAGTGATGATTATTACGAC
P1071c GCAGTCGACAGGTTGAATCTAGAAGGTATC
P1069 CGCGGATCCCCCAGTGATGATTATTACGAC
P1079 ATAGTCGACTCACAAGAATCCAGAACAACCthe 3A-like protein-VpG, while the 16 kDa fragment was the 3A-
like protein (Fig. 2B, lane 5). The identity of the 3A-like protein-
VpG fragment was further conﬁrmed by N-terminal sequencing.
The resulting amino acid sequence ‘‘SDEYP’’ was identical to the
expected N-terminus of the functional 3A-like protein.
Proteolytic cleavage between the 3A-like protein and Vpg.
Due to a small size upon the cleavage by protease, the Vpg protein
(10.8 kDa) is difﬁcult to isolate from a PAGE gel for N-terminal
sequencing analysis. Hence, a double fusion protein containing a
protein fragment from amino acid residues 632 to 779 with the
predicted cleavage site ﬂanked by the MBP and GST at the N- and
C-termini, respectively (Fig. 2A, F3) was expressed. Proteolytic
cleavage of this protein by the TV protease yielded a 42 kDa band
that was expected to be the MBP, a 32 kDa protein of the VpG-GST
fusion protein, and an unknown band of 19 kDa (Fig. 2C). The
N-terminal sequencing of the 32 kDa protein revealed a sequence
‘‘AKGKT’’ that was the expected N-terminal sequences of the
VpG-GST fusion protein.
Proteolytic cleavage between Vpg and the protease. The TV
polyprotein fragment containing the cleavage site between Vpg
and protease was fused to MBP at the N-terminus (Fig. 2A, F4).
To prevent potential auto-cleavage of the protease, we replaced
residue C134 with an A134 at the catalytic site of the protease.
Since the cleaved protease fragment from F4 would be the same
size as the active protease in trans, we fused GST to the
C-terminus of the protease. Upon cleavage, two cleavage
products, the 52.2 kDa MBP-VpG C-terminus and the 44.7 kDa
protease-GST, were produced. N-terminal sequencing analysis of
the 44.7 kDa fragment resulted in a perfect match to all of three
amino acid residues detected with the predicted N-terminal
sequence of TV protease (Fig. 3A).
Proteolytic cleavage between the protease and RdRp. The TV
polyprotein fragment containing the cleavage site between
the protease and RdRp (Fig. 2A, F5) was fused to GST at the
N-terminus. The cleavage of the 96.9 kDa F5 fragment was
expected to generate at least ﬁve smaller fragments: the
52.9 kDa RdRp, the 18 kDa protease, the 70.9 kDa protease-RdRp,
the 44 kDa GST-protease, and the 26 kDa GST. The N-terminus
sequencing of the 52.9 kDa fragment (RdRp) showed a perfect
match of the ﬁrst ﬁve amino acid residues GKTTY (Fig. 3B) with
that of the predicted RdRp.
Proteolytic cleavage between the NTP and helicase proteins.
We have also attempted to express a protein fragment contain-
ing the protease cleavage site between the N-terminal protein
and helicase protein using similar fusion expression strategies
(Fig. 2A, F1). Unfortunately, despite tremendous efforts, we wereagment cDNAs.
Restriction enzyme site Orientation Ampliﬁcations
BamHI Forward NoV protease
SalI Reverse
BamHI Forward TV protease
SalI Reverse
KpnI forward TV 3Al
SalI Reverse
BamHI Forward Polyprotein F1
SalI Reverse
EcoRI Forward Polyprotein F2
SalI Reverse
BamHI Forward Polyprotein F3
SalI Reverse
BamHI Forward Polyprotein F4
SalI Reverse
BamHI Forward Polyprotein F5
SalI Reverse
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portion of the N-terminal protein in either GST- or MBP- fusion, or
his-tagged forms.
Characterization of the enzymatic activities of the TV and
Norwalk virus proteases with ﬂuorogenic peptide substrates.
As demonstrated in the above polyprotein cleavage analysis,
E.coli-expressed proteases remain active upon puriﬁcation, which
makes possible to develop an in vitro antiviral screening system.
To this end, we evaluated the Norwalk virus protease activities
and the TV protease activities using synthetic ﬂuorogenic peptide
substrates NVS1 and TVS2 (Fig. 4A). In the presence of 2 nM NVS1,
as shown in Fig. 4(B), a dose response of enzyme activities was
observed in the reactions containing less than 5 mM of protease,
which was followed by a plateau at protease concentrations
between 5 and 20 uM. A similar ﬂuorescence emission proﬁle
was also observed when the ﬂuorogenic peptide substrate TVS2
was hydrolyzed by TV protease (Fig. 4C). These results indicate
that Hylite Fluor 488/QXL520-labled peptide substrates are
ideal for measuring recombinant Norwalk virus and TV protease
activities.
To determine the optimal reaction conditions for Norwalk
virus protease activity assay, we also performed the assays at
various pH, salt, glycerol and DMSO concentrations. At a constant
ionic strength (50 mM NaCl), the optimal pH for proteolytic
cleavage of Norwalk virus protease was found to be pH 8.5
(Fig. 5A), similar to that reported previously for NoV (Someya
et al., 2005) and for the NS3 protease of Dengue-2 virus (Leung
et al., 2001). The Norwalk virus protease activities decreased
signiﬁcantly as the NaCl concentration rose (from 50 mM to
300 mM, Fig. 5B). In contrast, glycerol in the reaction solution
seemed to promote protease activities (Fig. 5C). Based on these
observations, we used this buffer condition (50 mM Tris, pH 8.5,
20% glycerol, and 1 mM DTT) for all of our protease activity
assays. DMSO at concentrations less than 10% did not affect either
the Norwalk virus or TV protease activities.Fig. 1. Puriﬁcation of NoV and TV proteases. (A) Lane 1&2, puriﬁed GST-NoV protease f
released by thrombin digestion under various conditions. Lane 7, GST protein bound on
protein. Lane 11, TV protease released by thrombin digestion. (B) FPLC proﬁle of puriﬁThe TV and Norwalk virus proteases can partially cleavage
heterologous substrates. Although the TV and NoV proteases
share less than 27% amino acid sequence identity, the catalytic
triads are highly conserved (Fig. 6A), indicating that the TV and
NoV proteases may be able to process each other’s polyprotein
substrates. To test this hypothesis, we incubated the TV and
Norwalk virus proteases with each other’s substrates, and found
that both enzymes were able to cleave each other’s substrates,
although the relative enzymatic activities were around 30–40%,
compared with that on their native substrates (Fig. 6(B) and (C)).
Inhibition of the Norwalk virus protease activities. Since CV
proteases are cysteine proteases that display a trypsin or
chymotrypsin-like serine protease speciﬁcity, we tested whether
common cysteine and serine protease inhibitors could inhibit
the enzymatic activities of the Norwalk virus protease (Fig. 7A).
Among ﬁve inhibitors tested: E64, leupeptin, phenylmethyl sul-
fonyl ﬂuroride (PMSF), 1-Chloro-3-tosylamido-4-phenyl-2-buta-
none (TPCK), and 1-Chloro-3-tosylamido-7-amino-2-heptanone
HCl (TLCK), four – leupeptin, TPCK, TLCK, and PMSF – revealed
suppressive effects on NoV protease activities, with an IC50 of
18.8 mM for TPCK (Fig. 7B) and 175.1 mM for TLCK (Fig. 7C). These
results are consistent with a report by Blakeney et al. (Blakeney
et al., 2003).Discussion
Many RNA viruses encode their functional proteins in a single
open reading frame, where the proteins are translated as a poly-
protein prior to being processed by a viral protease into individual
functional proteins. Thus, the viral protease plays an essential role
in virus replication and pathogenesis. Like that of picornaviruses,
the CV proteases utilize a cysteine residue at its catalytic site as a
nucleophile (Zeitler et al., 2006). Based on sequence alignments of
several CV nonstructural proteins, we previously predicted theusion protein expressed at room temperature and at 37 1C; Lane 3-6, NoV protease
the beads. Lane 8, and 9, protein markers. Lane 10, puriﬁed GST-TV protease fusion
ed TV protease.
C. Wei et al. / Virology 436 (2013) 24–32 27location of the TV protease in the TV genome (Farkas et al., 2008).
In this study we have demonstrated that both the GST-fusion and
his-tagged TV proteases were functionally active using an in trans
assay on recombinant polyprotein fragments and synthetic
substrates. The precise boundaries of the protease were also mapped
by the N-terminal sequencing analysis.
In a parallel experiment, we also cloned and expressed the TV
protease with upstream sequences including the cleavage site for
the TV protease, and demonstrated that the TV protease is capable
of auto-cleavage and could release itself from the polyprotein. It is
also worthy to note that the expressed TV protease is able to
cleave the synthetic peptide containing nine amino acid residues,
suggesting that amino acid residues beyond P5 or P50 may be
dispensable for substrate processing by the protease. Successful
cleavage of a substrate containing seven amino acid residues by a
NoV protease has also been reported (Chang et al., 2012).
The cleavage maps for the nonstructural proteins of several
CVs revealed that the substrate cleavage sites of CV proteases are
well conserved in this virus family, in which a Glu or Gln is
usually present in the P1 position, whereas an Ala or Gly occupies
the P10 position. Based on this conservation of substrate cleavage
sites, we proposed a cleavage map for the TV nonstructural
polyprotein (Farkas et al., 2008). In this study, four of the ﬁve
predicted cleavage sites of the TV polyprotein have been experi-
mentally validated using recombinant polyprotein fragments by
in trans cleavage followed by N-terminal sequencing. The clea-
vage sites between Vpg and protease, and between protease and
RdRp share the same dipeptide residues of E/G. The amino acidFig. 2. Expression of TV polyprotein fragments for protease cleavage site mapping. (A) P
Each fusion protein contains at least one predicted protease cleavage site, as indicated b
GST; Grey boxes represent MBP. (B) Cleavage of fragment 2 (helicase-3Alike). Lane 1, pr
Lane 4 & 5 were detected with rabbit anti-3A like antibodies. The arrow indicates the
N-terminal sequencing were shown in the bracket. (C) Cleavage of fragment 3 (3A lik
fragment 3, bound fraction. Lane 4, digested fragment 3, supernatant fraction. The ar
The results of the N-terminal sequencing were shown in the bracket.residues at the other two sites seemed variable with Q/S between
the helicase and 3A-like protein and E/A between 3A-like protein
and Vpg. The cleavage at Q/S or E/A sites seems to be more
efﬁcient than at the E/G sites, according to the band intensities of
the cleaved products (data not shown). Although the cleavage site
between N-terminus protein and NTPase could not be validated
by the N-terminal sequence analysis, the Q/S scissile bond at
amino acid residues 233–234 remains to be the primary candi-
date for the cleavage, because this was the only one could
potentially be cleaved by TV protease within the adjacent 133
amino acid residues. Despite a lack of example for other calici-
virus proteases, our result on the cleavage between helicase and
3A-like protein suggested that the Q/S scissile bond could be an
efﬁcient cleavage site for CV protease (Fig. 2B).
In addition to the differences in scissile bonds at various cleavage
sites, amino acid residues at P2-5 and P20-50 also inﬂuence the
cleavage efﬁciencies of proteases (Nakamura et al., 2005; Oka et al.,
2009). As shown in Table 2, the protease cleavage sites of poly-
proteins from the CV family are well conserved. It is interesting to
note that a Q at the P1 position appears more often in between the
N-terminal protein and helicase, and between the helicase and 3A-
like protein; whereas an E at the P1 position appears more often
between Vpg and the protease and between the protease and RdRp.
Vpg, protease, and RdRp have been known to co-exist as precursor
protein fragments during the early stage of polyprotein processing
(Belliot et al., 2003). The differential preference for speciﬁc amino acid
residues at the P1 position could be one of the regulatory mechan-
isms in the control of polyprotein processing.redicted TV non-structural polyprotein and cloning strategy for mapping analysis.
y an arrow. Open boxes represent TV polyprotein fragments; Black boxes represent
otein markers. Lane 2 & 4, undigested fragment 2. Land 3 & 5, digested fragment 2.
protein fragment isolated for N-terminal sequencing analysis. The results of the
e-VpG). Lane 1, protein markers. Lane 2, undigested fragment 3. Land 3, digested
row indicates the protein fragment isolated for N-terminal sequencing analysis.
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recombinant TV protease and a NoV protease using FRET sub-
strates. FRET protease assays have been used in characterizationsFig. 3. Mapping of VpG-Pro and Pro-RdRp cleavage sites. (A) Cleavage of fragment
4 (VpG-protease). Lane 1, protein markers. Lane 2, undigested fragment 4. Land 3,
digested fragment 4, supernatant fraction. Lane 4, partially digested fragment 4,
bound fraction. The arrow indicates the protein fragment isolated for N-terminal
sequencing analysis. The results of the N-terminal sequencing were shown in the
bracket. (B) Cleavage of fragment 5 (pro-RdRp). Lane 1, protein markers. Lane
2 & 3, digested fragment 5. Land 4, undigested fragment 5. The arrow indicates the
protein fragment isolated for N-terminal sequencing analysis. The results of the
N-terminal sequencing were shown in the bracket.
Fig. 4. Determination of enzymatic activities of NoV and TV proteases. (A) Fluorogenic
derived from the cleavage site between N-terminal protein and helicase of NoV polypro
cleavage site between helicase and 3A-like of TV polyprotein. (B) Enzymatic activitiesof several viral proteases, such as those of the SARS-Coronavirus
(Blanchard et al., 2004; Grum-Tokars et al., 2008), hepatitis C
virus (Mao et al., 2008; Santos et al., 2009), yellow fever virus
(Kondo et al., 2011), and foot-and-month disease virus (Jaulent
et al., 2007). During the preparation of the manuscript, Chang
et al. also reported the characterization and inhibition of pro-
teases of two norovirus genogroups using FRET assays (Chang
et al., 2012). Unlike other reports on FRET protease activity assays,
the Hylite Fluor488 dye and QXL520 quencher were used to label
the peptide substrates in our study. Hylite Fluor488 is a new type
of ﬂuorophore that provides superior ﬂuorescence quantum yield
and a longer emission wavelength, whereas QXL520 has been
proven to be an efﬁcient quencher for Hylite Fluor488. The Hylite
Fluor 488/QXL520-based FRET peptide shows less interference
from autoﬂuorescence of test compounds, thus providing a better
assay sensitivity. Our results showed that this newly developed
ﬂuorescent dye and quencher pair was effective for the assay.
Optimization experiments with the NoV protease showed that the
protease was mostly active at a pH between 8 and 8.5, without
the need for additional ionic salts. This optimal pH is very similar
to that reported for the Chiba virus in NoV genogroup II (Someya
et al., 2005). While the presence of glycerol enhanced the
protease activities, a low concentration of DMSO (up to 10%) did
not affect the enzyme activities. This is important for our future
studies in the screening for inhibitors against the NoV protease,
because most synthetic compounds are dissolved in DMSO. We
also found that the TV and NoV proteases can cleave each other’s
substrate in the PRET assays. Since NoVs remain uncultivable
in vitro, the observed reciprocal enzymatic activities between the
NoV/TV proteases suggest that TV could serve as a surrogate for
NoVs in future antiviral designs targeting at the protease.
In summary, we have four out of the ﬁve cleavage sites of the
TV polyprotein conﬁrmed by protein N-terminal sequencing
analysis. We also established a convenient FRET assay system,
which will allow us to screen compound libraries for antiviralspeptide substrates NVS1 (HyliteFlour488-EPDFHLQGPEDLAKE-K (QXL520)–NH2),
tein; and TVS2 (Hylite Flour488-VWKMQSDEY-K(QXL520)–NH2), derived from the
of NoV protease, and (C) Enzymatic activities of TV protease.
C. Wei et al. / Virology 436 (2013) 24–32 29targeting the proteases of NoV/TV. In addition, we have demon-
strated speciﬁc inhibition of NoV/TV proteases by conventional
cysteine protease inhibitors. Furthermore, we have demonstrated
the reciprocal substrate cleavage between TV and NoV proteases.
Thus, we are in an excellent position to utilize the TV as a model
for in vivo screening and evaluation of candidates of protease
inhibitors for the uncultivable human NoVs.Fig. 5. Effects of pH, NaCl, glycerol, and DMSO on enzymatic activities of NoV protea
ﬂuorescence units at various reaction conditions to the one with the highest activities (1
strength (NaCl: 50 mM, 65.6 mM, 81.3 mM, 112.5 mM, 175 mM, and 300 mM). (C) Effect
at 0, 3.75, 7.5, 10, 15, and 20%. (D) Effect of DMSO. Same conditions as A at pH 8.5 wi
Fig. 6. Predicted secondary structures and active site residues in TV protease, and the re
structures and active site residues in TV protease. The predicted beta strands are represe
and red, respectively. Residues conserved or conservatively substituted (while conserv
using yellow background. Active site residues are highlighted in red, and residues in
binding cleft) are shown in blue. Notice that the active site and substrate binding cle
(B) The relative enzymatic activities of NoV protease on TV protease substrate TVS2, in
TV protease on NoV protease substrate NVS1, in comparison to on its native substrate TV
refferred to the web version of this article.)Methods
Fluorogenic substrates. Fluorogenic peptide substrates—
NVS1 (Hylite Fluor488-EPDFHLQGPEDLAKE-K (QXL520)-NH2)
and TVS2 (Hylite Fluor488-VWKMQSDEY-K(QXL520)-NH2) –
were designed based on the cleavage site between the
N-terminal protein and helicase of the NoV polyprotein (Belliotse. (A) Effect of pH. % of protease activity was determined by comparing relative
00%). (B) Effect of ionic strength. Same conditions as A at pH 8.5 with varying ionic
of glycerol concentration. Same conditions as A at pH 8.5 with addition of glycerol
th addition of DMSO at 0, 0.5, 1, 2, 4, 6, 8, and 10%.
ciprocal substrate cleavages of the TV and NoV proteases. (A) Predicted secondary
nted by green arrows, whereas predicted loops and helical turns are shown in blue
ing physico-chemical properties) between NoV and TV proteases are highlighted
contact with a peptide inhibitor in 2IPH (and thus deﬁning the overall substrate
ft are within regions conserved between NoV and TV proteases (yellow patches).
comparison to on its native substrate NVS1. (C) The relative enzymatic activities of
S2. (For interpretation of the references to color in this ﬁgure legend, the reader is
Fig. 7. Inhibition of NoV protease activities by common protease inhibitors. (A) Percent inhibition of NoV protease activities by E64, leupeptin, PMSF, TPCK, and TLCK.
(B) IC50 of TPCK on NoV protease activities; (C) IC50 of TLCK on NoV protease activities.
C. Wei et al. / Virology 436 (2013) 24–3230et al., 2003) or the cleavage site between the helicase and 3A-like
protein of the TV polyprotein (Farkas et al., 2008), respectively.
Both substrates were synthesized and labeled by Anaspec (CA).
The two ﬂuorophores on each substrate form a quenching pair
and exhibit FRET within the intact peptide. Upon the cleavage
between Q and G residues on NVS1 by NoV protease, or between
Q and S residues on TVS2 by TV protease (Fig. 4A), the donor
ﬂuorophore (Hylite Fluor488) separates from the quenching
ﬂuorophore (QXL520), allowing activities of protease to be mea-
sured. Stock solution of the ﬂuorogenic substrate was prepared in
dimethyl sulfoxide (DMSO), and subsequent dilution was pre-
pared with the assay buffer (50 mM Tris (pH 8.5), 20% glycerol,
and 1 mM DTT).
Generation of protease expression constructs. To express the
glutathione S-transferase (GST)-protease fusion proteins in E.coli,
protease coding sequences were ampliﬁed from NoV cDNA
(Genbank#: NC_001959) with primers p1405B and p1406
(Table 1), and TV cDNA (Genbank#: EU391643) with primers
p1069c and p1071b (Table 1), respectively, and were cloned into
vector pGEX4T1 (GE Health-care, PA) at BamHI/SalI sites.
To express N-terminal histidine (his)-tagged proteases, the same
inserts were cloned into vector pQE30 (Qiagen, CA) at the
identical cloning sites.
Generation of recombinant TV polyprotein fragment
expression constructs. To express TV polyprotein fragments
containing predicted protease cleavage sites in the forms of
maltose binding protein (MBP) or GST-fusion proteins, the corre-
sponding TV cDNAs (Genbank#: EU391643) were ampliﬁed with
speciﬁc primers (Table 1), and cloned into vector pMAL-c2X (New
England Biolab, MA) or vector pGEX4T1 (GE Health-care, PA)
(Fig. 2A).
Protein expression and puriﬁcation. GST-protease fusion
proteins, GST-polyprotein fragment fusion proteins, and MBP-
polyprotein fragment fusion proteins were expressed in E.coli
BL21 (DE3) plysS (EMD Millipore, MA) under the induction of
0.4 mM isopropyl b-D-1-thiogalactopyranoside (IPTG) overnightat room temperature. The his-tagged proteases were expressed in
E. coli M15 (Qiagen, CA) under the identical induction and culture
condition. The cells were harvested by centrifugation at 5000 g
for 15 min.
For GST-fusion protein puriﬁcation, the cell pellets were
resuspended in 1X PBS with 1 mM phenylmethylsulfonyl ﬂuoride
(PMSF). For MBP-fusion protein puriﬁcation, the cell pellets
were resuspended in column buffer (20 mM Tris–HCl, pH 7.4,
200 mM NaCl, 1 mM EDTA) with 1 mM PMSF. For his-tagged
protease puriﬁcation, the cell pellets were resuspended in cell
resuspension buffer (50 mM NaH2PO4, pH 8.0, 300 mM NaCl,
10 mM imidazole) with 1 mM PMSF. The cell resuspensions
were subjected to sonication, then cell lysates were centrifuged
at 12,000 g for 60 min. MBP-, GST-fusion and his-tagged pro-
teins were puriﬁed by afﬁnity chromatography using amylose
resins (New England Biolabs, MA), Glutathione Sepharose 4B
resins (GE Healthcare, PA), or Talon cell trus afﬁnity resins
(Clontech, CA).
Puriﬁed GST-fusion proteases were further digested with
thrombin and subsequently puriﬁed with gel permeation chro-
matography using a Superdex 200 gel ﬁltration column (GE
Healthcare, PA). The elution proﬁle was monitored by measuring
UV absorbance at 280 nm and the elution fractions were collected
and dialyzed with protease buffer (50 mM Tris–HCl, pH7.6, 1 mM
EDTA, 50 mM NaCl, 1 mM DTT) (Blakeney et al., 2003), while
his-tagged proteases were dialyzed with buffer containing 50 mM
NaH2SO4, pH4.5, 50 mM NaCl, 10 mM mercaptoethanol (Zeitler
et al., 2006). Proteases were then stored at 80 1C in small
aliquots. The purity of the proteins was veriﬁed with SDS PAGE
and protein concentrations were determined using the Bradford
protein concentration assay (BioRad, CA).
Protease activity analysis using ﬂuorogenic peptide sub-
strates. For protease activity assays, 2 mM of each protease
was mixed with 10 nM of ﬂuorogenic peptide substrate NVS1 or
TVS2 in protease buffer, and were transferred to black 96-well
non-treated microtiter plates (Corning, NY), with ﬁnal reaction
Table 2
Summary of veriﬁed protese cleavage sites of polyproteins in Calicivirus family.
Virus N-terminal protein/ NTPase NTPase/3A-like protein 3A-like protein/Vpg Vpg/protease Protease/RdRp Reference
hNoV (GI- Sothampton) LQ/GP LQ/GK ME/GK FE/AP LE/GG Liu et al. (1999)
hNoV (GII-MD145) LQ/GP LQ/GP TE/GK FE/AP LE/GD Belliot et al. (2003)
MNV AE/GP LQ/NK SE/GK FE/AP FQ/GP Sosnovtsev et al. (2006)
TV (PQ/SP) MQ/SD FE/AK DE/GY LE/GK Farkas et al. (2008)
& this paper
FCV SE/DV AE/NG SE/AK EE/SG / Sosnovtsev et al. (2002)
Sapovirus AQ/GP EQ/AG EE/AK EE/AP / Oka et al. (2005, 2009)
RHDV VE/GV FE/GA DQ/GV YE/GL ME/GK Joubert et al. (2000),
Wirblich et al. (1995)
C. Wei et al. / Virology 436 (2013) 24–32 31volume of 50 ml/well. The reaction mixtures were incubated
for 60 min at 37 1C. The ﬂuorescence was detected using Multi-
mode detector 880 (Beckman Coulter, CA) with excitation at
480 nm and emission at 520 nm, respectively. The protease
activities were determined from averages of duplicate or trip-
licate tests.
Optimization of reaction conditions. To determine the effects
of pH, ionic strength, glycerol, and dimethyl sulfoxide (DMSO) on
the enzymatic activities of the NoV protease, the concentrations
of individual buffer components in the standard protease activity
assay conditions described above were adjusted. The pH proﬁle
was determined at constant ionic strength with a pH range from
5.0 to 9.0, using a variety of buffers suitable for various pHs:
50 mM 2-(N-morpholino) ethanesulfonic acid (MES), 1 mM EDTA,
50 mM NaCl, 1 mM DTT for pH 5–6.5; or 50 mM Tris–HCl, 1 mM
EDTA, 50 mM NaCl, 1 mM DTT for pH 7–9 (Nall et al., 2004). The
percentage of enzymatic activities was determined by comparing
mean relative ﬂuorescent units (RFU) at various points to the
highest RFU in the same set of assays.
Polyprotein cleavage and peptide N-terminal sequencing.
Puriﬁed TV polyprotein fragments and puriﬁed TV protease were
incubated at room temperature overnight. The cleaved products
were run on SDS gels and blotted to PVDF membranes. After
staining with Coomassie brilliant blue R-250, the desired bands
were excised for the peptide N-terminal sequencing. The peptide
N-terminal sequencing services were performed by the protein
facility at Iowa State University, Ames, IA.
Prediction of the secondary structures and active site
residues in TV protease. BLASTp was used to align TV protease
sequence to the closest structurally resolved NoV protease (PDB
code 2IPH), which allowed us to map secondary structures from
the NoV template into TV protease between residues 18 and 162.
For the remaining N- and C-termini residues, secondary struc-
tures predicted by SABLE (http://sable.cchmc.org) are used to
provide the overall predicted structure of TV protease.
Inhibition assays. To allow formation of enzyme/inhibitor
complexes, 2 mM of each protease was pre-incubated with inhi-
bitors at desirable concentrations in protease buffer at room
temperature for 30 min. The proteolytic reaction was then
initiated by the addition of the ﬂuorogenic peptide substrates
(2.5 mM). The ﬁnal reaction mixtures were transferred to black,
96-well non-treated microtiter plates and were incubated for
60 min at 37 1C. The ﬂuorescence emissions were measured in
triplicate for each data point, as described above. Percent inhibi-
tion was determined by comparing the mean RFU of each reaction
with inhibitors to the corresponding mean RFU of the reaction
without inhibitors. The IC50 values were determined from reac-
tion mixtures containing various concentrations of inhibitors
ranging from 0 to 1000 mM.
Generation of mouse anti-TV-3Al antibodies. The coding
region of TV 3Al (aa574-712) was ampliﬁed with primers
p1282b and p1283b (Table 1), and was cloned into pQE30 vector(Qiagen). The his-TV3Al protein was then expressed in E.coli M15
(Qiagen) under the induction of 0.4 mM isopropyl b-D-1-thioga-
lactopyranoside (IPTG) for overnight at room temperature. The
cells were harvested by centrifugation at 5000 g for 15 min. To
purify the his-3Al protein, the cell pellets were resuspended 1x
lysis buffer (50 mM NaH2PO4, pH8.0, 300 mM NaCl, and 10 mM
imidazole) containing 1 mM phenylmethylsulfonyl ﬂuoride
(PMSF). The cell resuspensions were then subjected to sonication,
and the cell lysates were then centrifuged at 12,000 g for
60 min. The recombinant protein was puriﬁed by afﬁnity chro-
matography using TALON His-Tag Puriﬁcation Resin (Clonetech).
Mouse anti-TV3Al polycolonal antibodies were generated follow a
conventional antibody generation procedure.Acknowledgement
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